Trial intelligence / Profile preview

BTDS for Postoperative Pain Following TKA

NCT00403234Phase 2Terminated

Sponsor
Purdue Pharma
Start
Nov 2006
Primary completion
Apr 2007
Modality
Orthosteric Ligands, Inhalation Devices
Countries
1
01

Overview

A Phase 2 trial of v1003 in postoperative pain, sponsored by Purdue Pharma. Started Nov 2006; status: terminated.

02

Drugs

v1003
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT00403234.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00403234.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call